Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 30;12(7):1006.
doi: 10.3390/genes12071006.

The Genetics of Parkinson's Disease and Implications for Clinical Practice

Affiliations
Review

The Genetics of Parkinson's Disease and Implications for Clinical Practice

Jacob Oliver Day et al. Genes (Basel). .

Abstract

The genetic landscape of Parkinson's disease (PD) is characterised by rare high penetrance pathogenic variants causing familial disease, genetic risk factor variants driving PD risk in a significant minority in PD cases and high frequency, low penetrance variants, which contribute a small increase of the risk of developing sporadic PD. This knowledge has the potential to have a major impact in the clinical care of people with PD. We summarise these genetic influences and discuss the implications for therapeutics and clinical trial design.

Keywords: Parkinson’s disease; clinical trials; genetics; monogenic; polygenic; precision medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Summary of genetic variants in Parkinson’s disease grouped according to allele frequency and associated risk of Parkinson’s disease.

References

    1. GBD 2016 Neurology Collaborators Global, regional, and national burden of Parkinson’s disease, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:939–953. doi: 10.1016/S1474-4422(18)30295-3. - DOI - PMC - PubMed
    1. Jankovic J. Parkinson’s disease: Clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry. 2008;79:368–376. doi: 10.1136/jnnp.2007.131045. - DOI - PubMed
    1. Heinzel S., Berg D., Gasser T., Chen H., Yao C., Postuma R.B., MDS Task Force on the Definition of Parkinson’s Disease Update of the MDS research criteria for prodromal Parkinson’s disease. Mov. Disord. 2019;34:1464–1470. doi: 10.1002/mds.27802. - DOI - PubMed
    1. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry. 1992;55:181–184. doi: 10.1136/jnnp.55.3.181. - DOI - PMC - PubMed
    1. Postuma R.B., Berg D., Stern M., Poewe W., Olanow C.W., Oertel W., Obeso J., Marek K., Litvan I., Lang A.E., et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 2015;30:1591–1601. doi: 10.1002/mds.26424. - DOI - PubMed

Publication types